Lin Zhu

9PUBLICATIONS

11CO-AUTHORS

Pharmaceutical delivery technologiesRadiation therapyPredictive and prognostic markersCancer diagnosisAnimal production not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 08, 2026

Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer.

|Apr 29, 2026

Development and Preclinical Evaluation of Dual-Target 68Ga/177Lu-Labeled FAP-Bisphosphonate Radioligands with Enhanced Osteoma Retention.

|Aug 19, 2025

PSMA PET/CT for Improved Staging Accuracy and Imaging of Neovascularization-associated Features in Primary Lung Cancer.

Ruiyue Zhao, Jinhui Liu, Wanmei Liang

|May 05, 2025

Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CT.

Jiarou Wang, Linlin Li, Tianrui Feng

|Nov 05, 2024

Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.

Linlin Li, Guochang Wang, Jiarou Wang

|Jul 16, 2021

A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain.

Hao Xiao, Seok Rye Choi, Ruiyue Zhao

Pageof 2

Frequent Collaborators

Hank F Kung

Karl Ploessl

Rongxi Wang

Yaping Luo

Xinlu Wang

Zhaohui Zhu

Ruiyue Zhao

Jinhui Liu

Wanmei Liang

Shaoyu Liu

Frequent Collaborators

Hank F Kung

Karl Ploessl

Rongxi Wang

Yaping Luo